Arca Biopharma reported $5.68M in Operating Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Amgen AMGN:US $ 4.42B 680M
Arca Biopharma ABIO:US $ 5.68M 1.58M
Biogen BIIB:US $ 2648.2M 727.1M
Brainstorm Cell Therapeutics BCLI:US $ 5.48M 737K
Bristol Myers Squibb BMY:US $ 9.3B 202M
Capricor Therapeutics CAPR:US $ 7.32M 509.78K
Cytokinetics CYTK:US $ 99.84M 18.14M
Cytrx CYTR:US 1.29M 7.73M
Daiichi Sankyo 4568:JP 245.94B 38.74B
Gilead Sciences GILD:US $ 4231M 2162M
GlaxoSmithKline GSK:LN 5.85B 1.13B
Laboratory Of America LH:US $ 3171M 40.7M
Otsuka Holdings 4578:JP Y 387602M 28043M
Pfizer PFE:US $ 15640M 148M
United Therapeutics UTHR:US $ 265.1M 89.5M